Pfizer Inc and BioNTech Could Obtain Emergency Clearance in US and Europe for Their Covid-19 vaccine the next month, after the final results of the trial showed it had a 95% success rate and no serious side effects, drug makers said Wednesday. The efficacy of the vaccine was found to …
Read More »Pfizer-BioNTech Vaccine Deliveries Could Begin ‘Before Christmas’
